Evidence map›Paper›PMID 37582937›Full record

ArticleCommunications biology2023

Extracellular Pgk1 interacts neural membrane protein enolase-2 to improve the neurite outgrowth of motor neurons.

Chuan-Yang Fu, Hong-Yu Chen, Cheng-Yung Lin, Shiang-Jiuun Chen, Jin-Chuan Sheu, Huai-Jen Tsai

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. A 16-amino acid peptide delays the progression of motor neuron degeneration and pathogenic symptoms in ALS models.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Chuan-Yang FuDepartment of Life Science, Fu Jen Catholic University, New Taipei City, Taiwan.
Hong-Yu ChenInstitute of Molecular and Cellular Biology, National Taiwan University, Taipei, Taiwan.
Cheng-Yung LinInstitute of Biomedical Sciences, MacKay Medical College, New Taipei City, Taiwan.
Shiang-Jiuun ChenDepartment of Life Science and Institute of Ecology and Evolutionary Biology, National Taiwan University, Taipei, Taiwan.
Jin-Chuan SheuLiver Disease Prevention and Treatment Research Foundation, Taipei, Taiwan.
Huai-Jen TsaiDepartment of Life Science, Fu Jen Catholic University, New Taipei City, Taiwan. 012102@mail.fju.edu.tw.ORCID http://orcid.org/0000-0001-8242-4939
Fu Jen Catholic University · TWMackay Medical University · TWNational Taiwan University · TWNational Taiwan University of Science and Technology · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding the molecular interaction between ligand and receptor is important for providing the basis for the development of regenerative drugs. Although it has been reported that extracellular phosphoglycerate kinase 1 (Pgk1) can promote the neurite outgrowth of motoneurons, the Pgk1-interacting neural receptor remains unknown. Here we show that neural membranous Enolase-2 exhibits strong affinity with recombinant Pgk1-Flag, which is also evidently demonstrated by immunoelectron microscopy. The 325

Indexed as

Membrane ProteinsNeuritesPhosphoglycerate KinaseActin Depolymerizing FactorsMotor NeuronsNeuronal OutgrowthPhosphopyruvate HydrataseActin Depolymerizing FactorsMembrane ProteinsPhosphoglycerate KinasePhosphopyruvate Hydratase

Identifiers

PMID37582937
PMCPMC10427645
OpenAlexW4385839693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.